Skip to content

North Carolina Man Receives Maximum Sentence for Selling Dangerous Chemical for Weight Loss

The US Department of Justice announced recently that North Carolina resident Barry Clint Wright was sentenced to seven years in federal prison for his role in the online sale of 2,4-Dinitrophenol (DNP), a substance abused by bodybuilders and other people for weight-loss purposes. Wright, 38, received the maximum statutory sentence for introducing an unapproved drug into interstate commerce, introducing a misbranded drug into interstate commerce, and introducing an unapproved drug into interstate commerce with the intent to defraud or mislead.

Court records show that, for nearly three years, Wright operated websites that marketed DNP, which he purchased in bulk and then encapsulated into ingestible pills. Although he did not label the products as DNP or include directions for use along with products, many forums are available online that describe the intended use for DNP and give dosing information. Three of Wright's consumers died soon after consuming the substance.

DNP use has been linked to multiple deaths and, in April 2015, was the focus of an Interpol global health warning that described the imminent threat of DNP as a "lethal risk for the consumer." In mid-2018, a UK man was sentenced to seven years in prison for the death of a 21-year-old woman to whom he sold DNP online. Even so, the chemical remains widely available online for human consumption.

LegitScript continually identifies and monitors websites and merchants that market the chemical for human consumption. We are committed to stopping the sale of DNP marketed for human use and other dangerous chemicals that are abused for weight-loss purposes. We maintain the world's largest database of dietary supplements, designer drugs, pharmaceuticals, and other products such as DNP that are misbranded as dietary supplements. Members of the public can search a product in our database to see whether it contains dangerous, banned, or problematic ingredients.

Want to learn more about DNP and other problematic substances? Download LegitScript's Top 10 Problematic Ingredients guide.

 

David Khalaf is a writing, communications, and marketing professional with specialties in media, investigations, content strategy, and writing instruction. His 20 years of writing, media, and communications work have included two top-tier universities (USC and UCLA), print and digital magazines, consulting firms, and technology companies.

His current work involves content strategy and development at LegitScript, a company that helps the world's leading search engines, payment service providers, and internet platforms and marketplaces do business with legitimate, legally operating entities in more than 80 countries and 15 languages around the world. LegitScript specializes in risk and compliance for highly regulated industries including CBD/cannabis, online gambling, cryptocurrencies, drugs, financial trading, online adult, scams and fraud, and more.

Recent Blog Articles

Key Takeaways from HLTH 2025: Building Trust and Transparency in Healthcare

Last week's HLTH 2025 Conference brought together a remarkable community of healthcare leaders, innovators, and policymakers who are shaping the future of patient care. Across conversations about digital transformation, telehealth, regulation, and patient trust, the evolution of healthcare depends o...

Seeing Stars: How LegitScript and Regulators Fight the Sale of Fake Reviews

Consumer reviews and celebrity endorsements play a major role in how shoppers choose products online. Manufacturers' and retailers' awareness of this fact has led them to devote much of their marketing efforts to ensuring prospective customers hear only about the positive experiences of satisfied pa...
Dan Frechtling, LegitScript

Merchant Monitoring and the Power of AI + Human Expertise: A Conversation with Dan Frechtling

In the fast-evolving world of payments, managing merchant risk has never been more critical-or more complex. We sat down with Dan Frechtling, LegitScript's Senior Vice President of Product and Strategy, to discuss what sets LegitScript apart in the merchant monitoring landscape. In this Q&A, Dan...

How LegitScript Complies with Mastercard’s Merchant Monitoring Program (MMP)

What You Need to Know The latest revision to Mastercard's Merchant Monitoring Program (MMP) signals a major shift in how payments companies must manage compliance. The updated rules raise expectations for both onboarding and ongoing oversight, requiring acquirers to demonstrate deeper visibility int...